Regulation of serum phosphate

Area of Science:

• Endocrinology
• Nephrology
• Mineral Metabolism

Background:

• Serum phosphate is a critical risk factor for chronic kidney disease and cardiovascular mortality.
• Fibroblast growth factor 23 (FGF23) has emerged as a key regulator of phosphate homeostasis and vitamin D activation.
• Despite advances, the precise mechanisms regulating serum phosphate levels remain incompletely understood.

Purpose of the Study:

• To review the current understanding of phosphate homeostasis and the role of FGF23.
• To highlight the multifactorial nature of serum phosphate regulation.
• To identify gaps in knowledge regarding the integration of various hormonal and non-hormonal factors influencing phosphate levels.

Main Methods:

• Literature review and synthesis of existing research on phosphate metabolism.
• Analysis of the known and proposed regulatory pathways of FGF23.
• Discussion of the impact of various physiological and genetic factors on serum phosphate.

Main Results:

• FGF23, released by bone cells, regulates renal phosphate excretion and intestinal phosphate absorption via vitamin D.
• PTH and FGF23 exhibit opposing effects on vitamin D production, positioning vitamin D centrally in phosphate homeostasis.
• Diet, time of day, season, gender, age, genetics, and other hormones (dopamine, IGF, angiotensin II) significantly influence serum phosphate levels.

Conclusions:

• While FGF23 is a major phosphaturic hormone, the overall regulation of serum phosphate is complex and influenced by numerous factors.
• Further research is needed to elucidate how these diverse factors are integrated to maintain phosphate balance.
• Understanding these integrated mechanisms is crucial for managing conditions like chronic kidney disease and cardiovascular disease.